These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20529088)

  • 1. Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma).
    Atamas SP; Luzina IG; Ingels J; Choi J; Wong WK; Furst DE; Clements PJ; ; Postlethwaite AE
    Clin Exp Immunol; 2010 Sep; 161(3):426-35. PubMed ID: 20529088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supernatants from culture of type I collagen-stimulated PBMC from patients with cutaneous systemic sclerosis versus localized scleroderma demonstrate suppression of MMP-1 by fibroblasts.
    Brown M; Postlethwaite AE; Myers LK; Hasty KA
    Clin Rheumatol; 2012 Jun; 31(6):973-81. PubMed ID: 22367096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible contribution of visfatin to the resolution of skin sclerosis in patients with diffuse cutaneous systemic sclerosis via a direct anti-fibrotic effect on dermal fibroblasts and Th1 polarization of the immune response.
    Masui Y; Asano Y; Shibata S; Noda S; Akamata K; Aozasa N; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
    Rheumatology (Oxford); 2013 Jul; 52(7):1239-44. PubMed ID: 23443327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase disease.
    Postlethwaite AE; Wong WK; Clements P; Chatterjee S; Fessler BJ; Kang AH; Korn J; Mayes M; Merkel PA; Molitor JA; Moreland L; Rothfield N; Simms RW; Smith EA; Spiera R; Steen V; Warrington K; White B; Wigley F; Furst DE
    Arthritis Rheum; 2008 Jun; 58(6):1810-22. PubMed ID: 18512816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of PI3K Pathway Associated Molecules Reveals Dysregulated Innate and Adaptive Functions of B Cells in Early Diffuse Cutaneous Systemic Sclerosis.
    Simon D; Erdő-Bonyár S; Rapp J; Balogh P; Minier T; Nagy G; Czirják L; Berki T
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis.
    Noda S; Asano Y; Takahashi T; Akamata K; Aozasa N; Taniguchi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Rheumatology (Oxford); 2013 May; 52(5):790-9. PubMed ID: 23287360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.
    Mathes AL; Christmann RB; Stifano G; Affandi AJ; Radstake TR; Farina GA; Padilla C; McLaughlin S; Lafyatis R
    Ann Rheum Dis; 2014 Oct; 73(10):1864-72. PubMed ID: 23873879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation of the Wnt signaling pathway in South African patients with diffuse systemic sclerosis.
    Frost J; Estivill X; Ramsay M; Tikly M
    Clin Rheumatol; 2019 Mar; 38(3):933-938. PubMed ID: 30238381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
    Hasegawa M; Sato S; Takehara K
    Arch Dermatol Res; 2004 Jul; 296(2):89-93. PubMed ID: 15133694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival.
    Baker Frost D; Wolf B; Peoples C; Fike J; Silver K; Laffoon M; Medsger TA; Feghali-Bostwick C
    Arthritis Res Ther; 2019 Apr; 21(1):85. PubMed ID: 30940202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum adiponectin levels inversely correlate with the activity of progressive skin sclerosis in patients with diffuse cutaneous systemic sclerosis.
    Masui Y; Asano Y; Shibata S; Noda S; Aozasa N; Akamata K; Yamada D; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):354-60. PubMed ID: 21504484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis.
    Khan K; Xu S; Nihtyanova S; Derrett-Smith E; Abraham D; Denton CP; Ong VH
    Ann Rheum Dis; 2012 Jul; 71(7):1235-42. PubMed ID: 22586157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood cell gene expression profiling in rheumatoid arthritis. Discriminative genes and effect of rheumatoid factor.
    Bovin LF; Rieneck K; Workman C; Nielsen H; Sørensen SF; Skjødt H; Florescu A; Brunak S; Bendtzen K
    Immunol Lett; 2004 May; 93(2-3):217-26. PubMed ID: 15158620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Kadono T; Tamaki K; Takehara K
    Br J Rheumatol; 1997 Dec; 36(12):1270-5. PubMed ID: 9448587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts.
    He Y; Tsou PS; Khanna D; Sawalha AH
    Ann Rheum Dis; 2018 Aug; 77(8):1208-1218. PubMed ID: 29760157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune and Epstein-Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis.
    Veroni C; Marnetto F; Granieri L; Bertolotto A; Ballerini C; Repice AM; Schirru L; Coghe G; Cocco E; Anastasiadou E; Puopolo M; Aloisi F
    J Neuroinflammation; 2015 Jul; 12():132. PubMed ID: 26169064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups.
    Clark KEN; Xu S; Attah M; Ong VH; Buckley CD; Denton CP
    Ann Rheum Dis; 2023 Dec; 82(12):1568-1579. PubMed ID: 37580109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset.
    Rak JM; Pagni PP; Tiev K; Allanore Y; Farge D; Harlé JR; Launay D; Hachulla E; Didelot R; Cabane J; Kahan A; Martin M; Granel B; Roudier J; Lambert NC
    Rheumatology (Oxford); 2009 Apr; 48(4):363-6. PubMed ID: 19208687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen stimulation of peripheral blood mononuclear cells from Mycobacterium bovis infected cattle yields evidence for a novel gene expression program.
    Meade KG; Gormley E; O'Farrelly C; Park SD; Costello E; Keane J; Zhao Y; MacHugh DE
    BMC Genomics; 2008 Sep; 9():447. PubMed ID: 18823559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin expression is decreased in the involved skin and sera of diffuse cutaneous scleroderma patients.
    Arakawa H; Jinnin M; Muchemwa FC; Makino T; Kajihara I; Makino K; Honda N; Sakai K; Fukushima S; Ihn H
    Exp Dermatol; 2011 Sep; 20(9):764-6. PubMed ID: 21615510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.